Use of Fish Oils to Reduce Recurrence of Atrial Fibrillation Following DC Cardioversion
The purpose of this study is to investigate whether fish oil supplements may be beneficial in preventing the recurrence of atrial fibrillation after cardioversion.
Atrial fibrillation is a heart condition which can sometimes be successfully treated by a cardioversion.
Cardioversion involves resetting the heart back to normal with the use of electric current.
There is a tendency for the atrial fibrillation to recur , days weeks or even months after the cardioversion.
Fish oil supplements may be of benefit to patients with heart problems Recent evidence suggests that fish oils may be beneficial to patients with rhythm disturbances.
|Study Design:||Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||Use of Fish Oils to Reduce Recurrence of Atrial Fibrillation Following DC Cardioversion.|
- Recurrence of atrial fibrillation followed cardioversion [ Time Frame: 1 year ] [ Designated as safety issue: No ]
- Safety and tolerability [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]
|Study Start Date:||January 2003|
|Study Completion Date:||November 2013|
|Primary Completion Date:||November 2013 (Final data collection date for primary outcome measure)|
No Intervention: Control
No fish oil exposure
Experimental: Fish oil
Patients given 6g/day of fish oil containing 1.8g/d of EPA+DHA in a 1.5:1 ratio.
|Drug: Fish oil|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00232219
|Royal Melbourne hospital|
|Melbourne, Victoria, Australia, 3050|
|Principal Investigator:||Paul Sparks, MBBS, PhD. FRACP||Melbourne Health|